Immunotherapy of microsatellite stable colorectal cancer: resistance mechanisms and treatment strategies.
Postgrad Med J
; 100(1184): 373-381, 2024 May 18.
Article
in En
| MEDLINE
| ID: mdl-38211949
ABSTRACT
In recent years, immunotherapy strategies based on immune checkpoint inhibitors have yielded good efficacy in colorectal cancer (CRC)especially in colorectal cancer with microsatellite instability-high. However, microsatellite-stable (MSS) CRCs account for about 85% of CRCs and are resistant to immunotherapy. Previous studies have shown that compared with MSS CRC, high microsatellite instability CRC possesses a higher frequency of mutations and can generate more neoantigens. Therefore, improving the sensitivity of immunotherapy to MSS CRC is a hot topic which is crucial for the treatment of MSS CRC. This review aims to discuss the factors contributing to MSS CRC insensitivity to immunotherapy and explored potential solutions to overcome immunotherapy resistance.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Microsatellite Instability
/
Immune Checkpoint Inhibitors
/
Immunotherapy
Limits:
Humans
Language:
En
Journal:
Postgrad Med J
Year:
2024
Type:
Article
Affiliation country:
China